{
    "title": "Pfizer leans on COVID products to top estimates",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12037221/Pfizer-beats-profit-estimates-new-drugs-offset-COVID-products-slump.html",
    "date": "2023-05-02",
    "keywords": [
        "revenue",
        "quarter",
        "year",
        "pfizer",
        "profit",
        "demand",
        "growth",
        "company",
        "vaccine",
        "covid",
        "bhanvi",
        "satija",
        "mahobe",
        "forecast",
        "treatment",
        "street",
        "analyst",
        "share",
        "inc",
        "tuesday",
        "covid19",
        "point",
        "product",
        "wall",
        "mohit",
        "bansal",
        "surprise",
        "research",
        "hit",
        "patent",
        "decline",
        "capital",
        "string",
        "buyout",
        "seagen",
        "track",
        "goal",
        "number",
        "noncovid",
        "half",
        "officer",
        "david",
        "denton",
        "call",
        "andrew",
        "baum",
        "rsv",
        "colitis",
        "loss",
        "drug",
        "end",
        "approval",
        "market",
        "reporting",
        "raghav",
        "bengaluru",
        "michael",
        "erman",
        "york",
        "editing",
        "kalluvila",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}